Ceptur Therapeutics

Ceptur Therapeutics, Inc. is a preclinical-stage biotechnology company focused on developing targeted oligonucleotide therapies based on U1 Adapter technology. The company is developing unique and differentiated genetic medicines for patients with unmet diseases.